Acute Renal Failure

Rinaldo Bellomo

doi:10.1055/s-0031-1287872

Seminars in Respiratory and Critical Care Medicine, Inhaltsverzeichnis

Semin Respir Crit Care Med 2011; 32(5): 639-650
DOI: 10.1055/s-0031-1287872

Acute Renal Failure

Rinaldo Bellomo¹ ^, ² ^, ³ ^, ⁴

¹Department of Intensive Care, Austin Hospital, Melbourne, Victoria, Australia
²Department of Medicine, Austin Hospital, Melbourne, Victoria, Australia
³Department of Intensive Care, Melbourne University, Melbourne, Victoria, Australia
⁴Department of Medicine, Melbourne University, Melbourne, Victoria, Australia

Abstract

ABSTRACT

Acute renal failure (now acute kidney injury) is a common complication of critical illness affecting between 30 and 60% of critically ill patients. The development of a consensus definition (RIFLE—risk, injury, failure, loss, end-stage system) has allowed standardization of reporting and epidemiological work. Multicenter multinational epidemiological studies indicate that sepsis is now the most common cause of acute renal failure in the intensive care unit (ICU) followed by cardiac surgery–associated acute kidney injury. Unfortunately, our understanding of the pathogenesis of acute renal failure in these settings remains limited. Because of such limited understanding, no reproducibly effective therapies have been developed. In addition the diagnosis of acute renal failure still rests upon the detection of changes in serum creatinine, which only occur if more than 50% of glomerular filtration is lost and are often delayed by more than 24 hours. Such diagnostic delays make the implementation of early therapy nearly impossible. In response to these difficulties, there has been a concerted effort to use proteomics to identify novel early biomarkers of acute renal failure. The identification and study of neutrophil gelatinase– associated lipocalin has been an important step in this field. Another area of active interest and investigation relates to the role of intravenous fluid resuscitation and fluid balance. Data from large observational studies and randomized, controlled trials consistently indicate that a positive fluid balance in patients with acute renal failure represents a major independent risk factor for mortality and provides no protection of renal function. The pendulum is clearly swinging away from a fluid-liberal approach to a fluid-conservative approach in these patients. Finally, there is a growing appreciation that acute renal failure may identify patients who are at increased risk of subsequent chronic renal dysfunction and mortality, opening the way to post-ICU interventional trials.

KEYWORDS

Acute renal failure - acute kidney injury - acute tubular necrosis - creatinine - renal replacement therapy

Volltext

Referenzen

REFERENCES

1 Bellomo R, Ronco C, Kellum J A, Mehta R L, Palevsky P. Acute Dialysis Quality Initiative workgroup . Acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004; 8 (4) R204-R212
2 Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis. 2002; 39 (5) 930-936
3 Liangos O, Wald R, O'Bell J W, Price L, Pereira B J, Jaber B L. Epidemiology and outcomes of acute renal failure in hospitalized patients: a national survey. Clin J Am Soc Nephrol. 2006; 1 (1) 43-51
4 Macedo E, Mehta R L. Prerenal failure: from old concepts to new paradigms. Curr Opin Crit Care. 2009; 15 (6) 467-473
5 Feehally J, Floege J, Savill J, Turner A N. Glomerular injury and glomerular response. In: Davison A M, ed. Oxford Textbook of Clinical Nephrology. Oxford: Oxford University Press; 2005: 363-387
6 Stoegeman C A, Kallenberg C GM. Pathogenesis of angiitis. In: Davison A M, ed. Oxford Textbook of Clinical Nephrology. Oxford: Oxford University Press; 2005: 741-752
7 Heyman S N, Rosenberger C, Rosen S. Experimental ischemia-reperfusion: biases and myths-the proximal vs. distal hypoxic tubular injury debate revisited. Kidney Int. 2010; 77 (1) 9-16
8 Heyman S N, Lieberthal W, Rogiers P, Bonventre J V. Animal models of acute tubular necrosis. Curr Opin Crit Care. 2002; 8 (6) 526-534
9 Luyckx V A, Bonventre J V. Models of ischemic renal injury. In: Ronco C, Bellomo R, Kellum J A, eds. Critical Care Nephrology. Philadelphia, PA: Saunders Elsevier; 2009: 225-227
10 Heyman S N, Rosenberger C, Rosen S. Critical assessment of animal models of acute renal failure. In: Ronco C, Bellomo R, Kellum J A, eds. Critical Care Nephrology. Philadelphia, PA: Saunders Elsevier; 2009: 237-250
11 Langenberg C, Wan L, May C N, Bellomo R. Animal models of septic acute renal failure. In: Ronco C, Bellomo R, Kellum J A, eds. Critical Care Nephrology. Philadelphia, PA: Saunders Elsevier; 2009: 237-250
12 Ishikawa K, May C N, Gobe G, Langenberg C, Bellomo R. Pathophysiology of septic acute kidney injury: a different view of tubular injury. Contrib Nephrol. 2010; 165 18-27
13 Doi K, Leelahavanichkul A, Yuen P S, Star R A. Animal models of sepsis and sepsis-induced kidney injury. J Clin Invest. 2009; 119 (10) 2868-2878
14 Uchino S, Kellum J A, Bellomo R Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA. 2005; 294 (7) 813-818
15 Langenberg C, Bellomo R, May C N, Egi M, Wan L, Morgera S. Renal vascular resistance in sepsis. Nephron, Physiol. 2006; 104 (1) 1-11
16 Langenberg C, Bellomo R, May C, Wan L, Egi M, Morgera S. Renal blood flow in sepsis. Crit Care. 2005; 9 (4) R363-R374
17 Langenberg C, Wan L, Egi M, May C N, Bellomo R. Renal blood flow in experimental septic acute renal failure. Kidney Int. 2006; 69 (11) 1996-2002
18 Bellomo R, Wan L, Langenberg C, May C. Septic acute kidney injury: new concepts. Nephron, Exp Nephrol. 2008; 109 (4) e95-e100
19 Wan L, Bagshaw S M, Langenberg C, Saotome T, May C, Bellomo R. Pathophysiology of septic acute kidney injury: what do we really know?. Crit Care Med. 2008; 36 (4, Suppl) S198-S203
20 Langenberg C, Wan L, Egi M, May C N, Bellomo R. Renal blood flow and function during recovery from experimental septic acute kidney injury. Intensive Care Med. 2007; 33 (9) 1614-1618
21 Wan L, Yang N, Hiew C Y et al.. An assessment of the accuracy of renal blood flow estimation by Doppler ultrasound. Intensive Care Med. 2008; 34 (8) 1503-1510
22 Bagshaw S M, Uchino S, Bellomo R Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators et al. Septic acute kidney injury in critically ill patients: clinical characteristics and outcomes. Clin J Am Soc Nephrol. 2007; 2 (3) 431-439
23 Prowle J R, Molan M P, Hornsey E, Bellomo R. Ciné phase-contrast magnetic resonance imaging for the measurement of renal blood flow. Contrib Nephrol. 2010; 165 329-336
24 Prowle J R, Ishikawa K, May C N, Bellomo R. Renal plasma flow and glomerular filtration rate during acute kidney injury in man. Ren Fail. 2010; 32 (3) 349-355
25 Prowle J R, Echeverri J E, Ligabo E V, Ronco C, Bellomo R. Fluid balance and acute kidney injury. Nat Rev Nephrol. 2010; 6 (2) 107-115
26 Bagshaw S M, Bellomo R. Urine abnormalities in acute kidney injury and sepsis. Contrib Nephrol. 2010; 165 274-283
27 Bagshaw S M, Gibney R T. Acute kidney injury: clinical value of urine microscopy in acute kidney injury. Nat Rev Nephrol. 2009; 5 (4) 185-186
28 Macedo E, Malhotra R, Claure-Del Granado R, Fedullo P, Mehta R L. Defining urine output criterion for acute kidney injury in critically ill patients. Nephrol Dial Transplant. 2011; 26 (2) 509-515
29 Pannu N, Nadim M K. An overview of drug-induced acute kidney injury. Crit Care Med. 2008; 36 (4, Suppl) S216-S223
30 Bentley M L, Corwin H L, Dasta J. Drug-induced acute kidney injury in the critically ill adult: recognition and prevention strategies. Crit Care Med. 2010; 38 (6, Suppl) S169-S174
31 McCullough P A. Contrast-induced acute kidney injury. J Am Coll Cardiol. 2008; 51 (15) 1419-1428
32 Aspelin P, Aubry P, Fransson S G, Strasser R, Willenbrock R, Berg K J. Nephrotoxicity in High-Risk Patients Study of Iso-Osmolar and Low-Osmolar Non-Ionic Contrast Media Study Investigators . Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med. 2003; 348 (6) 491-499
33 McCullough P A. Radiocontrast-induced acute kidney injury. Nephron, Physiol. 2008; 109 (4) 61-72
34 Uchino S. Creatinine. Curr Opin Crit Care. 2010; Aug 21. [Epub ahead of print]
35 Bosch X, Poch E, Grau J M. Rhabdomyolysis and acute kidney injury. N Engl J Med. 2009; 361 (1) 62-72
36 Devarajan P, Krawczeski C D, Nguyen M T, Kathman T, Wang Z, Parikh C R. Proteomic identification of early biomarkers of acute kidney injury after cardiac surgery in children. Am J Kidney Dis. 2010; 56 (4) 632-642
37 Haase M, Haase-Fielitz A, Bellomo R, Mertens P R. Neutrophil gelatinase-associated lipocalin as a marker of acute renal disease. Curr Opin Hematol. 2010; Nov 22. [Epub ahead of print]
38 Maisel A S, Katz N, Hillege H L Acute Dialysis Quality Initiative Consensus Group et al. Biomarkers in kidney and heart disease. Nephrol Dial Transplant. 2011; 26 (1) 62-74
39 Bagshaw S M, Bellomo R. Cystatin C in acute kidney injury. Curr Opin Crit Care. 2010; Aug 21, [Epub ahead of print]
40 Walshe C M, Odejayi F, Ng S, Marsh B. Urinary glutathione S-transferase as an early marker for renal dysfunction in patients admitted to intensive care with sepsis. Crit Care Resusc. 2009; 11 (3) 204-209
41 Koyner J L, Vaidya V S, Bennett M R et al.. Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury. Clin J Am Soc Nephrol. 2010; 5 (12) 2154-2165
42 Devarajan P. Review: neutrophil gelatinase-associated lipocalin: a troponin-like biomarker for human acute kidney injury. Nephrology (Carlton). 2010; 15 (4) 419-428
43 Herget-Rosenthal S, Marggraf G, Hüsing J et al.. Early detection of acute renal failure by serum cystatin C. Kidney Int. 2004; 66 (3) 1115-1122
44 Mishra J, Dent C, Tarabishi R et al.. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet. 2005; 365 (9466) 1231-1238
45 Nickolas T L, O'Rourke M J, Yang J et al.. Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Ann Intern Med. 2008; 148 (11) 810-819
46 Parikh C R, Abraham E, Ancukiewicz M, Edelstein C L. Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit. J Am Soc Nephrol. 2005; 16 (10) 3046-3052
47 Bonventre J V. Kidney injury molecule-1 (KIM-1): a urinary biomarker and much more. Nephrol Dial Transplant. 2009; 24 (11) 3265-3268
48 Liu Y L, Prowle J, Licari E, Uchino S, Bellomo R. Changes in blood pressure before the development of nosocomial acute kidney injury. Nephrol Dial Transplant. 2009; 24 (2) 504-511
49 Bellomo R, Wan L, May C. Managing septic acute renal failure: “fill and spill”? “squeeze and diurese”? or “block Bax to the max”?. Crit Care Resusc. 2004; 6 (1) 12-16
50 Duke G J. Renal protective agents: a review. Crit Care Resusc. 1999; 1 (3) 265-275
51 Bellomo R, Chapman M, Finfer S, Hickling K, Myburgh J. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group . Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Lancet. 2000; 356 (9248) 2139-2143
52 Bagshaw S M, Delaney A, Haase M, Ghali W A, Bellomo R. Loop diuretics in the management of acute renal failure: a systematic review and meta-analysis. Crit Care Resusc. 2007; 9 (1) 60-68
53 Ortega R, Ginès P, Uriz J et al.. Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study. Hepatology. 2002; 36 (4 Pt 1) 941-948
54 Sagi S V, Mittal S, Kasturi K S, Sood G K. Terlipressin therapy for reversal of type 1 hepatorenal syndrome: a meta-analysis of randomized controlled trials. J Gastroenterol Hepatol. 2010; 25 (5) 880-885
55 Gluud L L, Christensen K, Christensen E, Krag A. Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome. Hepatology. 2010; 51 (2) 576-584
56 House A A, Haapio M, Lassus J, Bellomo R, Ronco C. Therapeutic strategies for heart failure in cardiorenal syndromes. Am J Kidney Dis. 2010; 56 (4) 759-773
57 Damman K, Navis G, Smilde T D et al.. Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction. Eur J Heart Fail. 2007; 9 (9) 872-878
58 Bagshaw S M, Cruz D N, Gibney R T, Ronco C. A proposed algorithm for initiation of renal replacement therapy in adult critically ill patients. Crit Care. 2009; 13 (6) 317
59 Bagshaw S M, Uchino S, Bellomo R Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators et al. Timing of renal replacement therapy and clinical outcomes in critically ill patients with severe acute kidney injury. J Crit Care. 2009; 24 (1) 129-140
60 Bagshaw S M, Berthiaume L R, Delaney A, Bellomo R. Continuous versus intermittent renal replacement therapy for critically ill patients with acute kidney injury: a meta-analysis. Crit Care Med. 2008; 36 (2) 610-617
61 Finfer S, Cass A, Gallagher M, Lee J, Su S, Bellomo R. RENAL Study Investigators . The RENAL (Randomised Evaluation of Normal vs. Augmented Level of Replacement Therapy) study: statistical analysis plan. Crit Care Resusc. 2009; 11 (1) 58-66
62 RENAL Study Investigators . Renal replacement therapy for acute kidney injury in Australian and New Zealand intensive care units: a practice survey. Crit Care Resusc. 2008; 10 (3) 225-230
63 RENAL Study Investigators . Screening and study enrollment in the RENAL replacement therapy trial. Blood Purif. 2009; 27 199-205
64 Palevsky P M, Zhang J H, O'Connor T Z VA/NIH Acute Renal Failure Trial Network et al. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med. 2008; 359 (1) 7-20
65 Bellomo R, Cass A, Cole L RENAL Replacement Therapy Study Investigators et al. Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med. 2009; 361 (17) 1627-1638
66 Mathew R, Mehta R. Anticoagulation strategies for continuous renal replacement therapy. In: Ronco C, Bellomo R, Kellum J A, eds. Critical Care Nephrology. Philadelphia, PA: Saunders Elsevier; 2009: 1342-1349
67 Bell M. Acute kidney injury: new concepts, renal recovery. Nephron Clin Pract. 2008; 109 (4) c224-c228
68 Uchino S, Bellomo R, Morimatsu H et al.. Discontinuation of continuous renal replacement therapy: a post hoc analysis of a prospective multicenter observational study. Crit Care Med. 2009; 37 (9) 2576-2582
69 Hobson C E, Yavas S, Segal M S et al.. Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery. Circulation. 2009; 119 (18) 2444-2453
70 Coca S G, Yusuf B, Shlipak M G, Garg A X, Parikh C R. Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis. 2009; 53 (6) 961-973
71 Golestaneh L, Melamed M L, Hostetter T H. Uremic memory: the role of acute kidney injury in long-term outcomes. Kidney Int. 2009; 76 (8) 813-814
72 Wald R, Quinn R R, Luo J University of Toronto Acute Kidney Injury Research Group et al. Chronic dialysis and death among survivors of acute kidney injury requiring dialysis. JAMA. 2009; 302 (11) 1179-1185
73 Waikar S S, Winkelmayer W C. Chronic on acute renal failure: long-term implications of severe acute kidney injury. JAMA. 2009; 302 (11) 1227-1229
74 Coca S G, Yusuf B, Shlipak M G, Garg A X, Parikh C R. Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis. 2009; 53 (6) 961-973

Rinaldo BellomoM.B.B.S. M.D.

Australian and New Zealand Intensive Care Research Centre, Monash University School of Public Health and Preventive Medicine

Commercial Rd., Prahran, Melbourne, Victoria 3084, Australia

eMail: rinaldo.bellomo@austin.org.au